Filed before 2025Filed 30 September 2014
VentiRx Pharmaceuticals Inc. raised $15M
VentiRx Pharmaceuticals Inc., a biotech company based in Seattle, WA, raised $15M in a new equity round, according to a filing dated 30 September 2014.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 30 September 2014
- Round
- Equity round
- Amount sold
- $15M
- Offering size
- $15M
- Investors so far
- 1
- Based in
- Seattle, WA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 76% of the 1,533 tracked raises with an amount filed in 2014, and than 67% of the 109 in biotech.
VentiRx Pharmaceuticals Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 30 Sep 2014 | New filing | $15M | This raise |
| 23 Sep 2014 | Amended filing | $50.6M | Another raise |
| 8 Mar 2012 | Amended filing | $18.8M | Another raise |
More with Frazier Life Sciences on the board
- Enlaza Therapeutics, Inc.$15M
- Sudo Biosciences, Inc.$63.6M
- MBX Biosciences, Inc.$46.7M
- 98point6 Inc.$20.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.